FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

827070004: Elexacaftor (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3873450012 Elexacaftor en Synonym Active Entire term case insensitive SNOMED CT core module
3873451011 Elexacaftor (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Elexacaftor Is a Pyridine true Inferred relationship Existential restriction modifier
Elexacaftor Has disposition Cystic fibrosis transmembrane conductance regulator potentiator true Inferred relationship Existential restriction modifier
Elexacaftor Is a Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing elexacaftor and ivacaftor and tezacaftor (medicinal product) Has active ingredient True Elexacaftor Inferred relationship Existential restriction modifier 3
Product containing elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form) Has active ingredient True Elexacaftor Inferred relationship Existential restriction modifier 3
Ivacaftor + Tezacaftor + Elexacaftor Has active ingredient True Elexacaftor Inferred relationship Existential restriction modifier 3
Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form) Has active ingredient True Elexacaftor Inferred relationship Existential restriction modifier 3
Generic Kaftrio 37.5mg/25mg/50mg tablets Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier
Generic Kaftrio 37.5mg/25mg/50mg tablets 56 tablet Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier
Kaftrio 37.5mg/25mg/50mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier
Generic Kaftrio 75mg/50mg/100mg tablets Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier
Kaftrio 75mg/50mg/100mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier
Generic Kaftrio 75mg/50mg/100mg tablets 56 tablet Has specific active ingredient True Elexacaftor Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start